Staubach, P.; Metz, M.; Chapman-Rothe, N. et al.
Omalizumab leads to a significant Reduction of Angioedema-Episodes in Patients with chronic spontaneous UrticariaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 86-87
Zimmer, Lisa; Eigentler, Thomas K.; Kiecker, Felix et al.
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanomaJOURNAL OF TRANSLATIONAL MEDICINE. Bd. 13. 2015
Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard et al.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trialLANCET ONCOLOGY. Bd. 16. H. 8. 2015 S. 908-918
Zuraw, B. L.; Cicardi, M.; Longhurst, H. J. et al.
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateALLERGY. Bd. 70. H. 10. 2015 S. 1319-1328
Krebs, F.; Uenal, Oe; Hahn, S. A. et al.
Phenotypical changes of melanoma cells and T cell subsets providing a loophole for relapse in Vemurafenib therapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 32-32
Tappertzhofen, Kristof; Weiser, Franziska; Montermann, Evelyn et al.
Poly-L-Lysine-Poly[HPMA] Block Copolymers Obtained by RAFT Polymerization as Polyplex-Transfection Reagents with Minimal ToxicityMACROMOLECULAR BIOSCIENCE. Bd. 15. H. 8. 2015 S. 1159-1173
Foerster, F.; Kaps, L.; Brose, A. et al.
PRECLINICAL EVALUATION OF DEXTRAN-BASED THERAPEUTIC NANOPARTICLES FOR HEPATIC DRUG DELIVERYJOURNAL OF HEPATOLOGY. Bd. 62. 2015 S. S426-S426
Staubach, P.; Melhorn, S.; Reimann, H. et al.
Prescription Formulation Tips for daily PracticeHAUTARZT. Bd. 66. H. 10. 2015 S. 793-794
Schmuecker, J. L. P.; Heinz, S.; Weidenthaler-Barth, B. et al.
Prolonged Remission of Angiosarcoma of the Scalp by means of RadiotherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 61-61
Ulges, Alexander; Klein, Matthias; Reuter, Sebastian et al.
Protein kinase CK2 enables regulatory T cells to suppress excessive T(H)2 responses in vivoNATURE IMMUNOLOGY. Bd. 16. H. 3. 2015 S. 267-U227